Alexion Pharmaceuticals Inc.*

NMS: ALXN
Chemicals
New Haven CT
Title 1Chairman
Executive 1Dr. Leonard Bell, M.D, Chairman | Chairman
2015 Revenue (US$ Millions)$2,604
2014 Revenue (US$ Millions)$2,234
Revenue Growth (%)16.58%
Net Income (US$ Millions)$144
Common Shares Outstanding (Millions)$226
Earnings Per Share (US$)$0.67
Price To Earnings Ratio305.65
Total Equity (US$ Millions)$8,259
Return On Equity (%)4.37%
Long Term Debt (US$ Millions)$3,433
Debt To Equity Ratio (%)0.42%
Market Capitalization (US$ Millions)$43,042
Total Assets (US$ Millions)$13,133
Current Assets (US$ Millions)$2,425
Inventories (US$ Millions)$290
Current Liabilities (US$ Millions)$718
Cost of Goods Sold (US$ Millions)$233
Asset Turnover0.2
Inventory Turnover1